Fischer Medical Ventures Statistics
Total Valuation
Fischer Medical Ventures has a market cap or net worth of INR 35.76 billion. The enterprise value is 35.39 billion.
Market Cap | 35.76B |
Enterprise Value | 35.39B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Fischer Medical Ventures has 53.50 million shares outstanding.
Shares Outstanding | 53.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 28.51% |
Owned by Institutions (%) | 6.76% |
Float | 5.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 32.77 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 1,826.03 |
EV / Sales | 109.43 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.63 |
Debt / FCF | n/a |
Interest Coverage | 14.50 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 3.85% |
Revenue Per Employee | 32.34M |
Profits Per Employee | 1.94M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +774.57% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +774.57% |
50-Day Moving Average | 640.95 |
200-Day Moving Average | 527.42 |
Relative Strength Index (RSI) | 55.82 |
Average Volume (20 Days) | 6,492 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fischer Medical Ventures had revenue of INR 323.45 million and earned 19.38 million in profits.
Revenue | 323.45M |
Gross Profit | 72.76M |
Operating Income | 25.63M |
Pretax Income | 22.99M |
Net Income | 19.38M |
EBITDA | n/a |
EBIT | 25.63M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 379.46 million in cash and 16.77 million in debt, giving a net cash position of 362.69 million or 6.78 per share.
Cash & Cash Equivalents | 379.46M |
Total Debt | 16.77M |
Net Cash | 362.69M |
Net Cash Per Share | 6.78 |
Equity (Book Value) | 811.25M |
Book Value Per Share | 20.40 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 22.50%, with operating and profit margins of 7.92% and 5.99%.
Gross Margin | 22.50% |
Operating Margin | 7.92% |
Pretax Margin | 7.11% |
Profit Margin | 5.99% |
EBITDA Margin | n/a |
EBIT Margin | 7.92% |
FCF Margin | n/a |
Dividends & Yields
Fischer Medical Ventures does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 27, 2017. It was a reverse split with a ratio of 0.05.
Last Split Date | Nov 27, 2017 |
Split Type | Reverse |
Split Ratio | 0.05 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |